These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15670540)

  • 1. Association of anemia with diastolic dysfunction among patients with coronary artery disease in the Heart and Soul Study.
    Nair D; Shlipak MG; Angeja B; Liu HH; Schiller NB; Whooley MA
    Am J Cardiol; 2005 Feb; 95(3):332-6. PubMed ID: 15670540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study.
    Ix JH; Shlipak MG; Chertow GM; Ali S; Schiller NB; Whooley MA
    J Card Fail; 2006 Oct; 12(8):601-7. PubMed ID: 17045178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters.
    Kirkpantur A; Kahraman S; Yilmaz R; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
    Artif Organs; 2005 Dec; 29(12):965-72. PubMed ID: 16305652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
    Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB
    Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional diastolic dysfunction in individuals with left ventricular hypertrophy measured by tagged magnetic resonance imaging--the Multi-Ethnic Study of Atherosclerosis (MESA).
    Edvardsen T; Rosen BD; Pan L; Jerosch-Herold M; Lai S; Hundley WG; Sinha S; Kronmal RA; Bluemke DA; Lima JA
    Am Heart J; 2006 Jan; 151(1):109-14. PubMed ID: 16368301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are hematinic deficiencies the cause of anemia in chronic heart failure?
    Witte KK; Desilva R; Chattopadhyay S; Ghosh J; Cleland JG; Clark AL
    Am Heart J; 2004 May; 147(5):924-30. PubMed ID: 15131553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nitric oxide--a potential modulator of left ventricular diastolic function in hemodialysis patients treated with erythropoietin].
    Rasić S; Kulenović I; Zulić I; Huskić J; Avdagić N; Babić N; Uncanin S; Haracić A
    Med Arh; 2004; 58(2):109-12. PubMed ID: 15202319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular filling abnormalities and obesity-associated hypertension: relationship with overproduction of circulating transforming growth factor beta1.
    Parrinello G; Licata A; Colomba D; Di Chiara T; Argano C; Bologna P; Corrao S; Avellone G; Scaglione R; Licata G
    J Hum Hypertens; 2005 Jul; 19(7):543-50. PubMed ID: 15944724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triphasic mitral inflow velocity with mid-diastolic flow: the presence of mid-diastolic mitral annular velocity indicates advanced diastolic dysfunction.
    Ha JW; Ahn JA; Moon JY; Suh HS; Kang SM; Rim SJ; Jang Y; Chung N; Shim WH; Cho SY
    Eur J Echocardiogr; 2006 Jan; 7(1):16-21. PubMed ID: 16378917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of anemia to low heart rate variability in patients with coronary heart disease (from the Heart and Soul study).
    Gehi A; Ix J; Shlipak M; Pipkin SS; Whooley MA
    Am J Cardiol; 2005 Jun; 95(12):1474-7. PubMed ID: 15950576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of optimized heart failure therapy and anemia correction with epoetin beta on left ventricular mass in hemodialysis patients.
    Hampl H; Hennig L; Rosenberger C; Amirkhalily M; Gogoll L; Riedel E; Scherhag A
    Am J Nephrol; 2005; 25(3):211-20. PubMed ID: 15900093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is echo-determined left ventricular geometry associated with ventricular filling and midwall shortening in hypertensive ventricular hypertrophy?
    Palmiero P; Maiello M; Nanda NC
    Echocardiography; 2008 Jan; 25(1):20-6. PubMed ID: 18186776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and prognosis of asymptomatic left ventricular diastolic dysfunction in ambulatory patients with coronary heart disease.
    Ren X; Ristow B; Na B; Ali S; Schiller NB; Whooley MA
    Am J Cardiol; 2007 Jun; 99(12):1643-7. PubMed ID: 17560867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular hypertrophy determines the severity of diastolic dysfunction in patients with nonvalvular atrial fibrillation and preserved left ventricular systolic function.
    Moon J; Rim SJ; Cho IJ; Lee SH; Choi S; Chung WJ; Byun YS; Ryu SK; Pyun WB; Kim JY
    Clin Exp Hypertens; 2010; 32(8):540-6. PubMed ID: 21091364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul study.
    Corteville DC; Bibbins-Domingo K; Wu AH; Ali S; Schiller NB; Whooley MA
    Arch Intern Med; 2007 Mar; 167(5):483-9. PubMed ID: 17353496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction.
    Melenovsky V; Borlaug BA; Rosen B; Hay I; Ferruci L; Morell CH; Lakatta EG; Najjar SS; Kass DA
    J Am Coll Cardiol; 2007 Jan; 49(2):198-207. PubMed ID: 17222731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is diastolic dysfunction associated with thrombogenesis? A study of circulating markers of a prothrombotic state in patients with coronary artery disease.
    Lip GY; Lowe GD; Metcalfe MJ; Rumley A; Dunn FG
    Int J Cardiol; 1995 Jun; 50(1):31-42. PubMed ID: 7558462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.